Back

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention

16 April 2023 (13:55 - 14:50)
Organised by:
Congress Presentation Part of: ePoster session 12 Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Mr Alwin Benedic Pascal Noordman

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Defibrillation testing during S-ICD implantation: How relevant? Results from a multicenter study.
Doctor M. BEN KILANI (Orleans, FR)
Abstract Slides
Presentation thumbnail
Beneficial effects of high output His bundle pacing in patients with heart failure, narrow QRS
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides
Presentation thumbnail
Transcatheter pacing system implant: is it a matter of gender?
Doctor V. Barletta (Pisa, IT)
Abstract Slides
Presentation thumbnail
Appropriate and inappropriate therapies in remotely monitored patients with cardiac implantable devices long-term experiences of a tertiary centre
Mr M. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Psychological stress in postural tachycardia syndrome: results of an online survey
Mr K. Firth (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 12

The Event

Event poster

EHRA 2023

16 April 2023 13:55 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources